Captrust Financial Advisors Intellia Therapeutics, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $152,971 - $213,605	-6,605 Reduced 34.11%	12,760 $389,000
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $72,346 - $104,744	2,288 Added 13.4%	19,365 $612,000
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $126,389 - $168,239	3,655 Added 27.23%	17,077 $696,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $23,809 - $32,046	-715 Reduced 5.06%	13,422 $500,000
Q4 2022 Feb 15, 2023	SELL	$33.21 - $62.69 $3,420 - $6,457	-103 Reduced 0.72%	14,137 $493,000
Q3 2022 Nov 16, 2022	BUY	$53.92 - $71.7 $203,278 - $270,309	3,770 Added 36.01%	14,240 $797,000
Q2 2022 Aug 23, 2022	SELL	$38.49 - $76.21 $143,914 - $284,949	-3,739 Reduced 26.31%	10,470 $542,000
Q2 2022 Aug 16, 2022	BUY	$38.49 - $76.21 $61,353 - $121,478	1,594 Added 12.64%	14,209 $735,000
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $475,191 - $970,363	-8,155 Reduced 39.26%	12,615 $917,000
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $365,255 - $501,555	3,625 Added 21.14%	20,770 $2.46 Million
Q3 2021 Nov 16, 2021	BUY	$132.37 - $176.78 $311,201 - $415,609	2,351 Added 15.89%	17,145 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $27,335 - $72,697	-449 Reduced 2.95%	14,794 $2.4 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $562,108 - $1.01 Million	12,065 Added 379.64%	15,243 $1.22 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $51,311 - $173,119	2,725 Added 601.55%	3,178 $173,000
Q3 2020 Nov 17, 2020	BUY	$17.47 - $24.93 $6,988 - $9,972	400 Added 754.72%	453 $9,000
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $590 - $1,212	53 New	53 $1,000
Q4 2018 Feb 13, 2019	SELL	$11.39 - $27.13 $2,927 - $6,972	-257 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$25.78 - $32.6 $3,042 - $3,846	-118 Reduced 31.47%	257 $7,000
Q2 2018 Aug 13, 2018	BUY	$20.02 - $30.79 $7,507 - $11,546	375 New	375 $10,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account